biosafety.kz

Research institute for biological safety problems

Science-projects and program

(IRN AP09258770) «Development of a Manufacturing Technology for an Inactivated Vaccine Against Camel Pox»

«Development of a Vaccine Against Coronavirus Infection COVID-19» «Development of a Vaccine Against Coronavirus Infection COVID-19»

«Identification and Preservation of Wheat Cultivars with Tolerance Mechanisms to Major Fungal Diseases»

Biological Safety of the Republic of Kazakhstan Threat Assessment, Scientific and Technical Foundations for Prevention and Elimination

BR22884615 Scientific Support for Epizootic Well-Being of Aquaculture and Livestock Enterprises in the Republic of Kazakhstan in Terms of Infectious and Parasitic Diseases for 2024–2026

Draft of the Targeted Funding Program ProjectDevelopment of New Diagnostic Test Systems for Especially Dangerous Viral InfectionsIRN BR24992948

IRN AP08856914 “Monitoring of arboviruses on the territory of the Republic of Kazakhstan”

IRN AP19676490“Bluetongue Primary Vectors, Distribution Area, and Genetic Characterization of the Virus Circulating in Kazakhstan, and the Introduction of a Specific Preventive Measure”

IRN AP19677632 “Metagenomics of the microbiome of ixodid ticks in Kazakhstan” 2023-2025

IRN AP23488595 Crimean-Congo Hemorrhagic Fever Monitoring and Study of Molecular-Genetic and Biological Characteristics of the Pathogen

IRN AR 09058338 Study of the antiviral activity of drugs against the SARS-COV-2 virus in vitro and conducting a molecular epidemiological analysis of circulating strains of COVID-19

IRN AR23485278 Search for Lytic Bacteriophages for the Development of Novel Therapeutic Agents to Treat Salmonellosis in Poultry

IRN AR23489672 “A Novel Phage-Based Biological Product for Combating Treponema pallidum”

IRNAP19676030 – IDENTIFICATION OF POTENTIAL RESERVOIRS OF CAMELPOX VIRUS IN WESTERN KAZAKHSTAN

АР08856376 «Improvement of the Capripoxvirus-Based Vaccine Vector»

АР08856376 «The Role of Viral Immunomodulatory Genes in Shaping the Immune Response to Capripoxvirus-Based Vector Vaccines»